Some people are making it their mission to get Novavax, rather than Pfizer or Moderna, for their COVID booster.

Novavax Inc. closed $10.57 below its 52-week high ($23.86), which the company reached on June 6th.

Pfizer and BioNTech said drug regulator Health Canada approved their updated Covid-19 vaccine, which will be available in the coming weeks.

A factor that has changed over time is hospitalization due to severe COVID infections. On Aug. 1, the statewide seven-day ...

There are currently no events scheduled on the LIVE7 digital channel. Check back soon to watch live events from across Canada ...

Pfizer-BioNTech's updated vaccine to protect against a recently circulating variant of COVID-19 is authorized, Health Canada said on Tuesday.

The mRNA vaccine, called Comirnaty, targets the KP.2 subvariant of Omicron, replacing the previous version which targeted the ...

On Monday, Novavax Inc (NVAX) stock saw a decline, ending the day at $12.8 which represents a decrease of $-0.11 or -0.85% from the prior close of $12.91. The stock opened at $13.01 and touched a low ...

Pfizer Canada says Health Canada has approved its updated COVID-19 vaccine that protects against one of the most recently ...

The NHS is offering autumn Covid boosters to the most vulnerable in October. Many pharmacies also now sell the Covid jab ...

There's a new bulletin from Florida's surgeon general. Vaccine experts and historians interviewed for this article can’t ...